Karger Publishers
Browse
487611sm_1.pdf (185.12 kB)

Supplementary Material for: Optical Coherence Tomography Angiography to Quantify Choroidal Neovascularization in Response to Aflibercept

Download (185.12 kB)
journal contribution
posted on 2018-05-08, 15:08 authored by Takeuchi J., Kataoka K., Ito Y., Takayama K., Yasuma T., Kaneko H., Terasaki H.
Purpose: To investigate the microvascular changes in choroidal0 neovascularization (CNV) using optical coherence tomography angiography (OCTA) during anti-vascular endothelial growth factor (VEGF) therapies. Methods: We retrospectively collected data on consecutive treatment-naïve eyes with typical age-related macular degeneration that initially received 3 aflibercept injections. OCTA was performed at baseline and at 1, 2, and 4 months of follow-up. The CNV images were analyzed using open-source software to assess vessel area and junction density. Results: Fifteen eyes of 15 patients were included. The mean vessel area at baseline was 0.50 ± 0.33 mm2; at 1, 2, and 4 months, the ratios of change in vessel area from baseline were 66.6 ± 38.8%, 80.5 ± 25.5%, and 94.0 ± 29.3%, respectively. The vessel area was significantly reduced at 1 month from that at baseline (p = 0.0015) but significantly increased at 4 months from that at 1 month (p = 0.011). The mean junction density was also significantly reduced from 4.70 ± 1.30/mm at baseline to 3.82 ± 1.06/mm at 1 month (p = 0.00084). However, junction density did not continue to decrease at 2 and 4 months. Conclusion: OCTA quantification revealed that CNV rebounded after repeat aflibercept injections despite shrinking in response to the first injection.

History

Usage metrics

    Ophthalmologica

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC